Related Experiment Video
Updated: Jun 25, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus
Gianni Marchetti1, Massimiliano Barolo, Lois Jovanovič
1DIPIC-Department of Chemical Engineering Principles and Practice, Università di Padova, via Marzolo 9, 35131 Padova (Italy).
Journal of Process Control
|February 5, 2009
Summary
Novel feedforward-feedback control strategies improve automated insulin delivery for type 1 diabetes. These advanced methods offer better glucose control, especially after meals, compared to standard insulin boluses.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Control Systems
Background:
- The development of an artificial pancreas is progressing, making automated insulin delivery systems more feasible.
- Real-time glucose monitoring is key to advanced diabetes management.
Purpose of the Study:
- To develop novel feedforward-feedback control strategies for real-time glucose control in type 1 diabetes.
- To explore methods for improving post-meal glucose responses.
Main Methods:
- Simulation of physiological models to evaluate control strategies.
- Development of feedforward-feedback control algorithms.
- Comparison with standard meal insulin bolus methods.
Main Results:
- Proposed strategies offer improved post-meal glucose control.
- Pre-prandial adjustments (snack, bolus, or setpoint reduction) enhance glucose regulation.
- Feedforward-feedback control presents viable alternatives to traditional insulin dosing.
Conclusions:
- Novel feedforward-feedback control strategies show promise for automated insulin delivery.
- These strategies can significantly improve glucose management in type 1 diabetes.
- Simulations indicate effectiveness in addressing post-meal glycemic excursions.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:01Feedback Loops
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.